Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Garmin CEO reveals startup origins, tech hiring challenges, culture of innovation
It began like any other startup, said Clifton Pemble, Garmin’s sixth employee and now CEO of the $11 billion GPS tech firm. “I joined Garmin and it was literally just days later that we were gathered in a little place over at 95th and Pflumm — two rooms in a small strip mall kind of…
1 Million Cups wraps month-long black entrepreneur showcase
Celebrating differences strengthens everyone, a white 1 Million Cups volunteer told a room full of black entrepreneurs and business owners Wednesday evening. “Diversity and inclusion are important to us year-round here at 1 Million Cups,” said Kyle Smith, communications coordinator at KCSourceLink and a 1MC Kansas City community organizer. “And I am very well aware…
C2FO raises massive $100M round for global expansion
In what is believed to be the largest venture-backed funding round in the Kansas City area’s history, C2FO is lighting the fuse on its global expansion with a $100 million capital raise. The Leawood-based financial tech firm’s round was led by Munich-based Allianz X and Abu Dhabi-based Mubadala Investment Company, and included participation from Temasek,…
Techweek KC returning with big LaunchKC, Techstars, BetaBlox demo days
One of Kansas City’s biggest conference series for entrepreneurs is returning in October alongside some of KC’s most premier accelerator programs, said Amanda Signorelli, CEO of Techweek KC. Demo days for Techstars KC and BetaBlox will join LaunchKC as signature events during the Oct. 8-12 conference, she said. “Combined with the nationally recognized LaunchKC competition…